SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-082186
Filing Date
2017-03-14
Accepted
2017-03-14 17:30:06
Documents
70
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d284545d10k.htm 10-K 1068895
2 EX-21.1 d284545dex211.htm EX-21.1 1551
3 EX-23.1 d284545dex231.htm EX-23.1 2189
4 EX-31.1 d284545dex311.htm EX-31.1 6792
5 EX-31.2 d284545dex312.htm EX-31.2 6793
6 EX-32.1 d284545dex321.htm EX-32.1 4358
13 GRAPHIC g284545g13s82.jpg GRAPHIC 53310
14 GRAPHIC g284545g57e16.jpg GRAPHIC 63460
15 GRAPHIC g284545g74h42.jpg GRAPHIC 133094
16 GRAPHIC g284545g79q95.jpg GRAPHIC 78048
  Complete submission text file 0001193125-17-082186.txt   5182599

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ntla-20161231.xml EX-101.INS 752832
8 XBRL TAXONOMY EXTENSION SCHEMA ntla-20161231.xsd EX-101.SCH 51924
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntla-20161231_cal.xml EX-101.CAL 65514
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntla-20161231_def.xml EX-101.DEF 168381
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20161231_lab.xml EX-101.LAB 430126
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20161231_pre.xml EX-101.PRE 308276
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 17689064
SIC: 2835 In Vitro & In Vivo Diagnostic Substances